Renin–Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Critical Care Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19
Crit. Care Med. 2022 Sep 01;50(9)1306-1317, GLY Rocheleau, T Lee, Y Mohammed, D Goodlett, K Burns, MP Cheng, K Tran, D Sweet, J Marshall, AS Slutsky, S Murthy, J Singer, DM Patrick, B Du, Z Peng, TC Lee, JH Boyd, KR Walley, F Lamontagne, R Fowler, BW Winston, G Haljan, DC Vinh, A McGeer, D Maslove, SP Patrigeon, P Mann, K Donohoe, G Hernandez, JA RussellFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.